Systemic absorption of topical tacrolimus in pyoderma gangrenosum [5]

Acta Dermato-Venereologica

Volumn 86, Issue 1, 2006, Pages 64-65

  Pitarch, Gerard ^a   Torrijos, Arantxa ^a   Mahiques, Laura ^a   Sánchez Carazo, José Luís ^a   Fortea, José Miguel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; INFLIXIMAB; METHYLPREDNISOLONE; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTERIAL PRESSURE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DIAGNOSTIC PROCEDURE; DRUG ABSORPTION; HUMAN; LETTER; LOCAL SKIN REACTION; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SIDE EFFECT; TREATMENT OUTCOME; BLOOD; MIDDLE AGED; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; TACROLIMUS;

EID: 33744729627     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550510040923     Document Type: Letter

References (9)

1. Lubbe J, Saurat JH. Monographie du tacrolimus topique (Protopic®). Ann Dermatol Venereol 2003; 130: 290-302.
2. Reitamo S, Wollenberg A, Schopf E, Perrot JL, Marks R, Ruzicka T, et al. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 2000; 136: 999-1006.
3. Vente C, Reich K, Rupprecht R, Neumann C. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 1999; 140: 338-342.
4. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, et al. Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001; 137: 747-750.
5. Bens G, Boralevi F, Buzenet C, Taïeb A. Topical treatment of Netherton's syndrome with tacrolimus ointment without significant systemic absorption. Br J Dermatol 2003; 149: 224-226.
6. Allen DM, Esterly NB. Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. Arch Dermatol 2002; 138: 1259-1260.
7. Ghislain PD, De Decker I, Marot L, Lachapelle JM. Efficacy and systemic absorption of topical tacrolimus used in pyoderma gangrenosum. Br J Dermatol 2004; 150: 1052-1053.
8. Teshima D, Ikesue H, Itoh Y, Urabe K, Furue M, Oishi R. Increased topical tacrolimus absorption in generalized leukemic erythroderma. Ann Pharmacother 2003; 37: 1444-1447.
9. Jolles S, Niclasse S, Benson E. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol 1999; 140: 564-565.